ANIMATION

Bavituximab Mechanism of Action (MOA)

Share this animation:

Together with Peregrine, we helped depict the mechanism of action behind Bavituximab, an investigational treatment that helps the body recognize cancer cells. Upregulated expression of phosphatidylserine by cancer cells contributes to their ability to avoid destruction by the immune system. Bavituximab targets phosphatidylserine, thereby encouraging active immune activity in cancerous environments.

Share It:
Contact XVIVO

Client


Peregrine Pharmaceuticals, Inc.

I wanted to thank XVIVO for creating the animation and doing so at record speed! I received wonderful feedback from people at TED about the video – everyone thought it was so cool and wanted to know who made it.

President & CEO, The International AIDS Vaccine Initiative
Share this animation: